In total, 563 circadian genes were differently expressed in hepatocellular carcinoma; three of them—CSNK1D, CSNK1E and NPAS2—had a high correlation with the overall survival rate in LIHC patients [7]. The gene discussed is NPAS2; the disease is hepatocellular carcinoma.